# US 2003/0228650 A1 · Methods for the identification of inhibitors of Methylenetetrahydrofolate reductase as antibiotics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228650 A1
- Document ID: US20030228650A1
- Status: Published application
- Kind: A1
- Application number: 10/437,334
- Filed: 2003-05-13
- Published: 2003-12-11
- Earliest claimed: 2002-05-17
- Inventors: Amy Skalchunes; Huaqin Pan; Rex Tarpey; Jeffrey Shuster; Matthew M. Tanzer; Lisbeth Hamer; Kiichi Adachi; M. DeZwaan Todd; Sze-Chung Lo; Maria Victoria Montenegro-Chamorro; Sheryl Frank; Blaise Darveaux; Sanjoy Mahanty; Ryan Heiniger
- Web page: https://patentgrep.com/patent/US20030228650A1

## CPC

- C12Q 1/18: Testing for antimicrobial activity of a material
- C12Q 1/26: involving oxidoreductase
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present inventors have discovered that Methylenetetrahydrofolate reductase is essential for fungal pathogenicity. Specifically, the inhibition of Methylenetetrahydrofolate reductase gene expression in fungi results in an inability to form lesions and non-pathogenicity. Thus, Methylenetetrahydrofolate reductase can be used as a target for the identification of antibiotics, preferably antifungals. Accordingly, the present invention provides methods for the identification of compounds that inhibit Methylenetetrahydrofolate reductase expression or activity. The methods of the invention are useful for the identification of antibiotics, preferably antifungals.

## Claims

### Claim 1

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) contacting a Methylenetetrahydrofolate reductase polypeptide with a test compound; and
b) detecting the presence or absence of binding between said test compound and said Methylenetetrahydrofolate reductase polypeptide, wherein binding indicates that said test compound is a candidate for an antibiotic.

### Claim 2 (depends on 1)

The method of claim 1, wherein said Methylenetetrahydrofolate reductase polypeptide is a fungal Methylenetetrahydrofolate reductase polypeptide.

### Claim 3 (depends on 1)

The method of claim 1, wherein said Methylenetetrahydrofolate reductase polypeptide is a Magnaporthe Methylenetetrahydrofolate reductase polypeptide.

### Claim 4 (depends on 1)

The method of claim 1, wherein said Methylenetetrahydrofolate reductase polypeptide is SEQ ID NO: 3.

### Claim 5 (depends on 1)

A method for determining whether the antibiotic candidate of claim 1 has antifungal activity, further comprising: contacting a fungus or fungal cells with said antibiotic candidate and detecting the decrease in growth, viability, or pathogenicity of said fungus or fungal cells.

### Claim 6

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) contacting a test compound with at least one polypeptide selected from the group consisting of: a polypeptide having at least ten consecutive amino acids of a fungal Methylenetetrahydrofolate reductase, a polypeptide having at least 50% sequence identity with a fungal Methylenetetrahydrofolate reductase, and a polypeptide having at least 10% of the activity thereof; and
b) detecting the presence and/or absence of binding between said test compound and said polypeptide, wherein binding indicates that said test compound is a candidate for an antibiotic.

### Claim 7 (depends on 6)

A method for determining whether the antibiotic candidate of claim 6 has antifungal activity, further comprising: contacting a fungus or fungal cells with said antibiotic candidate and detecting a decrease in growth, viability, or pathogenicity of said fungus or fungal cells.

### Claim 8

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) contacting 5,10-methylenetetrahydrofolate and NADPH with a Methylenetetrahydrofolate reductase;
b) contacting 5,10-methylenetetrahydrofolate and NADPH with Methylenetetrahydrofolate reductase and a test compound; and
c) determining the change in concentration for at least one of the following: 5,10-methylenetetrahydrofolate, 5-methyltetrahydrofolate, NADPH, and/or NADP+, wherein a change in concentration for any of the above substances between steps (a) and (b) indicates that said test compound is a candidate for an antibiotic.

### Claim 9 (depends on 8)

The method of claim 8, wherein said Methylenetetrahydrofolate reductase is a fungal Methylenetetrahydrofolate reductase.

### Claim 10 (depends on 8)

The method of claim 8, wherein said Methylenetetrahydrofolate reductase is a Magnaporthe Methylenetetrahydrofolate reductase.

### Claim 11 (depends on 8)

The method of claim 8, wherein said Methylenetetrahydrofolate reductase is SEQ ID NO: 3.

### Claim 12 (depends on 8)

A method for determining whether the antibiotic candidate of claim 8 has antifungal activity, further comprising: contacting a fungus or fungal cells with said antibiotic candidate and detecting a decrease in growth, viability, or pathogenicity of said fungus or fungal cells.

### Claim 13

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) contacting 5-methyltetrahydrofolate and NADP+ with a Methylenetetrahydrofolate reductase;
b) contacting 5-methyltetrahydrofolate and NADP+ with a Methylenetetrahydrofolate reductase and a test compound; and
c) determining the change in concentration for at least one of the following: 5,10-methylenetetrahydrofolate, 5-methyltetrahydrofolate, NADPH, and/or NADP+, wherein a change in concentration for any of the above substances between steps (a) and (b) indicates that said test compound is a candidate for an antibiotic.

### Claim 14 (depends on 13)

The method of claim 13, wherein said Methylenetetrahydrofolate reductase is a fungal Methylenetetrahydrofolate reductase.

### Claim 15 (depends on 13)

The method of claim 13, wherein said Methylenetetrahydrofolate reductase is a Magnaporthe Methylenetetrahydrofolate reductase.

### Claim 16 (depends on 13)

The method of claim 13, wherein said Methylenetetrahydrofolate reductase is SEQ ID NO: 3.

### Claim 17 (depends on 13)

A method for determining whether the antibiotic candidate of claim 13 has antifungal activity, further comprising: contacting a fungus or fungal cells with said antibiotic candidate and detecting a decrease in growth, viability, or pathogenicity of said fungus or fungal cells.

### Claim 18

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) contacting 5,10-methylenetetrahydrofolate and NADPH with a polypeptide selected from the group consisting of: a polypeptide having at least 50% sequence identity with Methylenetetrahydrofolate reductase, a polypeptide having at least 50% sequence identity with a Methylenetetrahydrofolate reductase and having at least 10% of the activity thereof, and a polypeptide comprising at least 100 consecutive amino acids of a Methylenetetrahydrofolate reductase;
b) contacting 5,10-methylenetetrahydrofolate and NADPH with said polypeptide and a test compound; and
c) determining the change in concentration for at least one of the following: 5,10-methylenetetrahydrofolate, 5-methyltetrahydrofolate, NADPH, and/or NADP+, wherein a change in concentration for any of the above substances between steps (a) and (b) indicates that said test compound is a candidate for an antibiotic.

### Claim 19

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) contacting 5-methyltetrahydrofolate and NADP+ with a polypeptide selected from the group consisting of: a polypeptide having at least 50% sequence identity with a Methylenetetrahydrofolate reductase, a polypeptide having at least 50% sequence identity with a Methylenetetrahydrofolate reductase and at least 10% of the activity thereof, and a polypeptide comprising at least 100 consecutive amino acids of a Methylenetetrahydrofolate reductase;
b) contacting 5-methyltetrahydrofolate and NADP+, with said polypeptide and a test compound; and
c) determining the change in concentration for at least one of the following: 5,10-methylenetetrahydrofolate, 5-methyltetrahydrofolate, NADPH, and/or NADP+, wherein a change in concentration for any of the above substances between steps (a) and (b) indicates that said test compound is a candidate for an antibiotic.

### Claim 20

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) measuring the expression of a Methylenetetrahydrofolate reductase in a cell, cells, tissue, or an organism in the absence of a test compound;
b) contacting said cell, cells, tissue, or organism with said test compound and measuring the expression of said Methylenetetrahydrofolate reductase in said cell, cells, tissue, or organism; and
c) comparing the expression of Methylenetetrahydrofolate reductase in steps (a) and (b), wherein a lower expression in the presence of said test compound indicates that said test compound is a candidate for an antibiotic.

### Claim 21 (depends on 20)

The method of claim 20, wherein said cell, cells, tissue, or organism is, or is derived from a fungus.

### Claim 22 (depends on 20)

The method of claim 20, wherein said cell, cells, tissue, or organism is, or is derived from a Magnaporthe fungus or fungal cell.

### Claim 23 (depends on 20)

The method of claim 20, wherein said Methylenetetrahydrofolate reductase is SEQ ID NO: 3.

### Claim 24 (depends on 20)

The method of claim 20, wherein the expression of Methylenetetrahydrofolate reductase is measured by detecting MTHFR-1 mRNA.

### Claim 25 (depends on 20)

The method of claim 20, wherein the expression of Methylenetetrahydrofolate reductase is measured by detecting Methylenetetrahydrofolate reductase polypeptide.

### Claim 26

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) providing cells having one form of a Methylenetetrahydrofolate reductase gene, and providing comparison cells having a different form of a Methylenetetrahydrofolate reductase gene; and
b) contacting said cells and said comparison cells with a test compound and determining the growth of said cells and comparison cells in the presence of the test compound, wherein a difference in growth between said cells and said comparison cells in the presence of said compound indicates that said compound is a candidate for an antibiotic.

### Claim 27 (depends on 26)

The method of claim 26, wherein the cells and the comparison cells are fungal cells.

### Claim 28 (depends on 26)

The method of claim 26, wherein the cells and the comparison cells are Magnaporthe cells.

### Claim 29 (depends on 26)

The method of claim 26, wherein said form and said different form of the Methylenetetrahydrofolate reductase are fungal Methylenetetrahydrofolate reductases.

### Claim 30 (depends on 26)

The method of claim 26, wherein at least one of the forms is a Magnaporthe Methylenetetrahydrofolate reductase.

### Claim 31 (depends on 26)

The method of claim 26, wherein said form and said different form of the Methylenetetrahydrofolate reductase are non-fungal Methylenetetrahydrofolate reductases.

### Claim 32 (depends on 26)

The method of claim 26, wherein one form of the Methylenetetrahydrofolate reductase is a fungal Methylenetetrahydrofolate reductase, and the different form is a non-fungal Methylenetetrahydrofolate reductase.

### Claim 33

A method for identifying a test compound as a candidate for an antibiotic, comprising:
a) providing cells having one form of a gene in the methionine biochemical and/or genetic pathway and providing comparison cells having a different form of said gene;
b) contacting said cells and said comparison cells with a said test compound; and
c) determining the growth of said cells and said comparison cells in the presence of said test compound, wherein a difference in growth between said cells and said comparison cells in the presence of said test compound indicates that said test compound is a candidate for an antibiotic.

### Claim 34 (depends on 33)

The method of claim 33, wherein the cells and the comparison cells are fungal cells.

### Claim 35 (depends on 33)

The method of claim 33, wherein the cells and the comparison cells are Magnaporthe cells.

### Claim 36 (depends on 33)

The method of claim 33, wherein said form and said different form of the methionine biosynthesis gene are fungal methionine biosynthesis genes.

### Claim 37 (depends on 33)

The method of claim 33, wherein at least one of the forms is a Magnaporthe methionine biosynthesis gene.

### Claim 38 (depends on 33)

The method of claim 33, wherein said form and said different form of the methionine biosynthesis genes are non-fungal Methionine biosynthesis genes.

### Claim 39 (depends on 33)

The method of claim 33, wherein one form of the methionine biosynthesis gene is a fungal methionine biosynthesis gene, and the different form is a non-fungal methionine biosynthesis gene.

### Claim 40 (depends on 33)

A method for determining whether the antibiotic candidate of claim 33 has antifungal activity, further comprising: contacting a fungus or fungal cells with said antibiotic candidate and detecting a decrease in growth, viability, or pathogenicity of said fungus or fungal cells, wherein a decrease in growth, viability, or pathogenicity of said fungus or fungal cells indicates that the antibiotic candidate has antifungal activity.

### Claim 41

A method for identifying a test compound as a candidate for an antibiotic, comprising:
(a) providing paired growth media comprising a first medium and a second medium, wherein said second medium contains a higher level of methionine than said first medium;
(b) contacting an organism with a test compound;
(c) inoculating said first and said second media with said organism; and
(d) determining the growth of said organism, wherein a difference in growth of the organism between said first and said second media indicates that said test compound is a candidate for an antibiotic.

### Claim 42 (depends on 41)

The method of claim 41, wherein said organism is a fungus.

### Claim 43 (depends on 41)

The method of claim 41, wherein said organism is Magnaporthe.

### Claim 44

An isolated nucleic acid comprising a nucleotide sequence that encodes a polypeptide of SEQ ID NO: 3.

### Claim 45 (depends on 44)

The nucleic acid of claim 44, comprising the nucleotide sequence of SEQ ID NO: 1.

### Claim 46 (depends on 45)

An expression cassette comprising the nucleic acid of claim 45.

### Claim 47 (depends on 44)

The isolated nucleic acid of claim 44, comprising a nucleotide sequence with at least 50 to at least 95% sequence identity to SEQ ID NO: 1.

### Claim 48

An isolated polypeptide consisting essentially of the amino acid sequence of SEQ ID NO: 3.

### Claim 49

An isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 3.
